Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Baxter
Fuji
QuintilesIMS
Johnson and Johnson
Mallinckrodt
Argus Health
Merck

Generated: July 15, 2018

DrugPatentWatch Database Preview

Fluciclovine f-18 - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for fluciclovine f-18 and what is the scope of fluciclovine f-18 freedom to operate?

Fluciclovine f-18
is the generic ingredient in one branded drug marketed by Blue Earth and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Fluciclovine f-18 has thirty-three patent family members in thirteen countries.

One supplier is listed for this compound.
Summary for fluciclovine f-18
International Patents:33
US Patents:2
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 5
Clinical Trials: 8
Patent Applications: 16
DailyMed Link:fluciclovine f-18 at DailyMed
Pharmacology for fluciclovine f-18
Synonyms for fluciclovine f-18
(18F)FACBC
(18F)Fluciclovine
(18F)Ge-148
(1R,3R)-1-Amino-3(18f)fluorocyclobutane-1-carboxylic acid
[18F]-FACBC
[18F]FACBC
[18F]Fluciclovine
1-amino-3-fluoranylcyclobutane-1-carboxylic acid
18F fluciclovine
18F-Ge-148
222727-39-1
38R1Q0L1ZE
AC1L9P1E
AKOS030238192
anti-(18f)FABC
Anti-[18F]FACBC
anti-1-Amino-3-(18f)fluorocyclobutane-1-carboxylic acid
Anti-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid
Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic-acid
Anti-1-amino-3-F-18-fluorocyclobutane-1-carboxylic-acid
Anti-1-amino-3-fluorine-18-fluorocyclobutane-1-carboxylic acid
Anti-18-F-FACBC
Anti-18F-FABC
Anti-3-18F-FACBC
Anti-F-18-fluorocyclobutane-carboxylic-acid
axumin
AxuminCN FACBCCN Fluciclovine (18F)CN GE 148CN NMK 36
CHEBI:134703
CHEMBL254468
CHEMBL447701
D03QIP
D10860
DB13146
FACBC
FACBC F-18
Fluciclovine
Fluciclovine ((sup 18)F)
Fluciclovine ((sup 18)F) [INN]
Fluciclovine (18F)
Fluciclovine (18F) (INN)
Fluciclovine (18F) [INN]
Fluciclovine F 18
Fluciclovine F18 [USAN]
Fluciclovine-F-18
GE-148
Ge-148 (18F)
Ge-148 F-18
Ge-148-18F
Ge-148-F-18
MOLI001120
NMK36
SCHEMBL10017245
SCHEMBL11939897
SCHEMBL11939900
syn-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid
syn-3-[18F]FACBC
Trans-1-amino-3-18F-fluorocyclobutanecarboxylic-acid
UNII-38R1Q0L1ZE

US Patents and Regulatory Information for fluciclovine f-18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Blue Earth AXUMIN fluciclovine f-18 SOLUTION;INTRAVENOUS 208054-001 May 27, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Blue Earth AXUMIN fluciclovine f-18 SOLUTION;INTRAVENOUS 208054-001 May 27, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Blue Earth AXUMIN fluciclovine f-18 SOLUTION;INTRAVENOUS 208054-001 May 27, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for fluciclovine f-18

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,758,724 Unnatural amino acid radiolabeling precursor ➤ Sign Up
9,381,259 Precursor compound of radioactive halogen-labeled organic compound ➤ Sign Up
5,817,776 Amino acid analogs for tumor imaging ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Daiichi Sankyo
Queensland Health
Covington
Colorcon
QuintilesIMS
Federal Trade Commission
Medtronic
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.